Kala Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
3.33 |
41.35 |
25.00 |
26.12 |
62.92 |
107.50 |
| Przychód Δ r/r |
0.00% |
1140.38% |
-39.53% |
4.47% |
140.90% |
70.85% |
| Przychód (min) |
3.33 |
41.35 |
25.00 |
26.12 |
62.92 |
107.50 |
| Przychód (max) |
3.33 |
41.35 |
25.00 |
26.12 |
62.92 |
107.50 |
| EBITDA (średnia) |
-0.67 |
-8.27 |
-5.00 |
-5.22 |
-12.58 |
-21.50 |
| EBIT (średnia) |
-0.67 |
-8.27 |
-5.00 |
-5.22 |
-12.58 |
-21.50 |
| EBIT % |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
-20.00% |
| Zysk netto (średni) |
-59.78 |
-28.96 |
-18.33 |
-19.43 |
-6.73 |
-4.69 |
| Zysk netto % |
-1793.53% |
-70.05% |
-73.31% |
-74.40% |
-10.70% |
-4.36% |
| EPS (średnia) |
-10.84 |
-5.25 |
-3.32 |
-3.52 |
-1.22 |
-0.85 |
| Liczba analityków (Przychody) |
2 |
3 |
2 |
1 |
1 |
1 |
| Liczba analityków (EPS) |
1 |
1 |
2 |
1 |
1 |
1 |
| symbol |
KALA |
KALA |
KALA |
KALA |
KALA |
KALA |